ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 108 filers reported holding ALBIREO PHARMA INC in Q4 2020. The put-call ratio across all filers is 2.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $19,990,763 | +11.6% | 925,070 | -0.0% | 0.01% | 0.0% |
| Q3 2022 | $17,914,000 | +3.3% | 925,304 | +6.0% | 0.01% | +11.1% |
| Q2 2022 | $17,335,000 | +21.5% | 872,898 | +82.5% | 0.01% | +50.0% |
| Q1 2022 | $14,267,000 | +101.4% | 478,303 | +57.3% | 0.01% | +100.0% |
| Q4 2021 | $7,084,000 | -16.3% | 304,152 | +12.1% | 0.00% | 0.0% |
| Q3 2021 | $8,465,000 | -11.3% | 271,307 | 0.0% | 0.00% | -25.0% |
| Q2 2021 | $9,545,000 | +8.3% | 271,307 | +8.5% | 0.00% | 0.0% |
| Q1 2021 | $8,813,000 | -6.0% | 250,007 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $9,378,000 | +12.4% | 250,007 | +0.0% | 0.00% | 0.0% |
| Q3 2020 | $8,343,000 | – | 250,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 514,082 | $11,973,000 | 7.17% |
| Privium Fund Management B.V. | 379,117 | $8,959,000 | 1.78% |
| Birchview Capital, LP | 113,000 | $2,632,000 | 1.70% |
| Sio Capital Management, LLC | 213,913 | $4,982,000 | 1.50% |
| Perceptive Advisors | 4,720,278 | $109,936,000 | 0.85% |
| Chicago Capital, LLC | 849,239 | $19,779,000 | 0.74% |
| APOGEM CAPITAL LLC | 38,601 | $899,000 | 0.59% |
| Samsara BioCapital, LLC | 100,000 | $2,329,000 | 0.45% |
| Artal Group S.A. | 600,000 | $13,974,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 458,011 | $10,667,000 | 0.38% |